Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Anais brasileiros de dermatologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000400001 |
Resumo: | Abstract: Chromoblastomycosis is a chronic, granulomatous, suppurative mycosis of the skin and subcutaneous tissue caused by traumatic inoculation of dematiaceous fungi of the family Herpotrichiellaceae. The species Fonsecaea pedrosoi and Cladophialophora carrionii are prevalent in regions where the disease is endemic. Chromoblastomycosis lesions are polymorphous: verrucous, nodular, tumoral, plaque-like, and atrophic. It is an occupational disease that predominates in tropical and subtropical regions, but there have been several reports of cases in temperate regions. The disease mainly affects current or former farm workers, mostly males, and often leaving disabling sequelae. This mycosis is still a therapeutic challenge due to frequent recurrence of lesions. Patients with extensive lesions require a combination of pharmacological and physical therapies. The article provides an update of epidemiological, clinical, diagnostic, and therapeutic features. |
id |
SBD-1_6c033b513f2f58cf017b512f5afb55f8 |
---|---|
oai_identifier_str |
oai:scielo:S0365-05962018000400001 |
network_acronym_str |
SBD-1 |
network_name_str |
Anais brasileiros de dermatologia (Online) |
repository_id_str |
|
spelling |
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment updateChromoblastomycosisDiagnosisDiagnostic tests, routineEpidemiologyFungiTherapeuticsTreatment outcomeAbstract: Chromoblastomycosis is a chronic, granulomatous, suppurative mycosis of the skin and subcutaneous tissue caused by traumatic inoculation of dematiaceous fungi of the family Herpotrichiellaceae. The species Fonsecaea pedrosoi and Cladophialophora carrionii are prevalent in regions where the disease is endemic. Chromoblastomycosis lesions are polymorphous: verrucous, nodular, tumoral, plaque-like, and atrophic. It is an occupational disease that predominates in tropical and subtropical regions, but there have been several reports of cases in temperate regions. The disease mainly affects current or former farm workers, mostly males, and often leaving disabling sequelae. This mycosis is still a therapeutic challenge due to frequent recurrence of lesions. Patients with extensive lesions require a combination of pharmacological and physical therapies. The article provides an update of epidemiological, clinical, diagnostic, and therapeutic features.Sociedade Brasileira de Dermatologia2018-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000400001Anais Brasileiros de Dermatologia v.93 n.4 2018reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20187321info:eu-repo/semantics/openAccessBrito,Arival Cardoso deBittencourt,Maraya de Jesus Semblanoeng2018-07-26T00:00:00Zoai:scielo:S0365-05962018000400001Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2018-07-26T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false |
dc.title.none.fl_str_mv |
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update |
title |
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update |
spellingShingle |
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update Brito,Arival Cardoso de Chromoblastomycosis Diagnosis Diagnostic tests, routine Epidemiology Fungi Therapeutics Treatment outcome |
title_short |
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update |
title_full |
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update |
title_fullStr |
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update |
title_full_unstemmed |
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update |
title_sort |
Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update |
author |
Brito,Arival Cardoso de |
author_facet |
Brito,Arival Cardoso de Bittencourt,Maraya de Jesus Semblano |
author_role |
author |
author2 |
Bittencourt,Maraya de Jesus Semblano |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Brito,Arival Cardoso de Bittencourt,Maraya de Jesus Semblano |
dc.subject.por.fl_str_mv |
Chromoblastomycosis Diagnosis Diagnostic tests, routine Epidemiology Fungi Therapeutics Treatment outcome |
topic |
Chromoblastomycosis Diagnosis Diagnostic tests, routine Epidemiology Fungi Therapeutics Treatment outcome |
description |
Abstract: Chromoblastomycosis is a chronic, granulomatous, suppurative mycosis of the skin and subcutaneous tissue caused by traumatic inoculation of dematiaceous fungi of the family Herpotrichiellaceae. The species Fonsecaea pedrosoi and Cladophialophora carrionii are prevalent in regions where the disease is endemic. Chromoblastomycosis lesions are polymorphous: verrucous, nodular, tumoral, plaque-like, and atrophic. It is an occupational disease that predominates in tropical and subtropical regions, but there have been several reports of cases in temperate regions. The disease mainly affects current or former farm workers, mostly males, and often leaving disabling sequelae. This mycosis is still a therapeutic challenge due to frequent recurrence of lesions. Patients with extensive lesions require a combination of pharmacological and physical therapies. The article provides an update of epidemiological, clinical, diagnostic, and therapeutic features. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000400001 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000400001 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/abd1806-4841.20187321 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Dermatologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Dermatologia |
dc.source.none.fl_str_mv |
Anais Brasileiros de Dermatologia v.93 n.4 2018 reponame:Anais brasileiros de dermatologia (Online) instname:Sociedade Brasileira de Dermatologia (SBD) instacron:SBD |
instname_str |
Sociedade Brasileira de Dermatologia (SBD) |
instacron_str |
SBD |
institution |
SBD |
reponame_str |
Anais brasileiros de dermatologia (Online) |
collection |
Anais brasileiros de dermatologia (Online) |
repository.name.fl_str_mv |
Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD) |
repository.mail.fl_str_mv |
abd@sbd.org.br||revista@sbd.org.br |
_version_ |
1752126422943531008 |